Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease

• Hauptverfasser: Hee Young Ju (Verfasst von), Hyoung Jin Kang (Verfasst von), Che Ry Hong (Verfasst von), Ji Won Lee (Verfasst von), Hyery Kim (Verfasst von), Sang Hoon Song (Verfasst von), Kyung-Sang Yu (Verfasst von), In-Jin Jang (Verfasst von), June Dong Park (Verfasst von), Kyung Duk Park (Verfasst von), Hee Young Shin (Verfasst von), Joong-Gon Kim (Verfasst von), Hyo Seop Ahn (Verfasst von)
• Format: Buch
• Veröffentlicht: Korean Pediatric Society, 2016-11-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Chronic granulomatous disease (CGD) is a primary immunodeficiency disease caused by impaired phagocytic function. Hematopoietic stem cell transplantation (HSCT) is a definitive cure for CGD; however, the use of HSCT is limited because of associated problems, including transplantation-related mortali...